Erkinjuntti T - Search Results

1

The concept of vascular cognitive impairment.

Erkinjuntti T, Gauthier S. Erkinjuntti T, et al. Front Neurol Neurosci. 2009;24:79-85. doi: 10.1159/000197886. Epub 2009 Jan 26. Front Neurol Neurosci. 2009. PMID: 19182465 Review.

2

Vascular cognitive impairment.

O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. O'Brien JT, et al. Among authors: erkinjuntti t. Lancet Neurol. 2003 Feb;2(2):89-98. doi: 10.1016/s1474-4422(03)00305-3. Lancet Neurol. 2003. PMID: 12849265 Review.

3

Emerging therapies for vascular dementia and vascular cognitive impairment.

Erkinjuntti T, Román G, Gauthier S, Feldman H, Rockwood K. Erkinjuntti T, et al. Stroke. 2004 Apr;35(4):1010-7. doi: 10.1161/01.STR.0000120731.88236.33. Epub 2004 Mar 4. Stroke. 2004. PMID: 15001795

4

Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.

Erkinjuntti T, Román G, Gauthier S. Erkinjuntti T, et al. Neurol Res. 2004 Jul;26(5):603-5. doi: 10.1179/01610425017631. Neurol Res. 2004. PMID: 15265282 Review.

5

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.

Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Erkinjuntti T, et al. Lancet. 2002 Apr 13;359(9314):1283-90. doi: 10.1016/S0140-6736(02)08267-3. Lancet. 2002. PMID: 11965273 Clinical Trial.

6

Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.

Erkinjuntti T, Román G, Gauthier S. Erkinjuntti T, et al. J Neurol Sci. 2004 Nov 15;226(1-2):63-6. doi: 10.1016/j.jns.2004.09.018. J Neurol Sci. 2004. PMID: 15537522 Review.

7

Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular disease.

Kurz AF, Erkinjuntti T, Small GW, Lilienfeld S, Damaraju CR. Kurz AF, et al. Among authors: erkinjuntti t. Eur J Neurol. 2003 Nov;10(6):633-40. doi: 10.1046/j.1468-1331.2003.00677.x. Eur J Neurol. 2003. PMID: 14641507 Clinical Trial.

8

Vascular cognitive deterioration and stroke.

Erkinjuntti T. Erkinjuntti T. Cerebrovasc Dis. 2007;24 Suppl 1:189-94. doi: 10.1159/000107395. Epub 2007 Nov 1. Cerebrovasc Dis. 2007. PMID: 17971655 Review.

9

Subcortical ischaemic vascular dementia.

Román GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Román GC, et al. Among authors: erkinjuntti t. Lancet Neurol. 2002 Nov;1(7):426-36. doi: 10.1016/s1474-4422(02)00190-4. Lancet Neurol. 2002. PMID: 12849365 Review.

10

Physical activity prevents progression for cognitive impairment and vascular dementia: results from the LADIS (Leukoaraiosis and Disability) study.

Verdelho A, Madureira S, Ferro JM, Baezner H, Blahak C, Poggesi A, Hennerici M, Pantoni L, Fazekas F, Scheltens P, Waldemar G, Wallin A, Erkinjuntti T, Inzitari D; LADIS Study. Verdelho A, et al. Among authors: erkinjuntti t. Stroke. 2012 Dec;43(12):3331-5. doi: 10.1161/STROKEAHA.112.661793. Epub 2012 Nov 1. Stroke. 2012. PMID: 23117721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters